Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Mediastinal leiomyosarcoma].

J B Auliac1, A Cuvelier, C Peillon

  • 1Département de Bois-Guillaume, Rouen.

Revue Des Maladies Respiratoires
|May 26, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Influence of smoking on the efficacy of immunotherapy in advanced lung cancers].

Revue des maladies respiratoires·2025
Same author

Hypoxic burden and sleep hypoventilation in obese patients.

Sleep medicine·2024
Same author

[High-flow nasal oxygen therapy and hypercapnic acute respiratory failure].

Revue des maladies respiratoires·2024
Same author

Poor sleep quality and nocturnal home noninvasive ventilation: Prevalence, risk factors and impact.

Pulmonology·2023
Same author

[French clinical practice guidelines for the diagnosis and management of lung disease with alpha 1-antitrypsin deficiency].

Revue des maladies respiratoires·2022
Same author

[Alpha1-antitrypsin deficiency: French guidelines… at last !]

Revue des maladies respiratoires·2022
Same journal

[French version of the guidelines for connective tissue disease-associated ILD].

Revue des maladies respiratoires·2026
Same journal

[Pulmonary expression of an asymptomatic lysosomal storage disorder].

Revue des maladies respiratoires·2026
Same journal

[Factors associated with FEV1 evolution in cystic fibrosis patients treated by CFTR modulator tritherapy].

Revue des maladies respiratoires·2026
Same journal

[Subacute pulmonary coccidioidomycosis: A differential diagnosis of lung cancer].

Revue des maladies respiratoires·2026
Same journal

[Relevance of the ACT score in severe asthma with obesity: A pilot study].

Revue des maladies respiratoires·2026
Same journal

[Automated analysis of mandibular movements for the screening of obstructive sleep apnea].

Revue des maladies respiratoires·2026
See all related articles

Mediastinal leiomyosarcomas are rare smooth muscle tumors. Diagnosis requires specific markers, and treatment involves surgery, radiotherapy, or chemotherapy, with prognosis depending on tumor characteristics.

Area of Science:

  • Oncology
  • Pathology
  • Surgical Oncology

Background:

  • Leiomyosarcomas originate from smooth muscle cells, rarely occurring in the mediastinum.
  • Mediastinal leiomyosarcomas are exceptionally rare, often arising from small vessels within the mediastinum.

Observation:

  • Clinical symptoms like dysphagia and dysphonia result from large tumor size compressing mediastinal structures.
  • Gross pathology reveals a single-cell tumor, while microscopic examination may necessitate immune markers (actin, desmin) or ultrastructural analysis for definitive diagnosis.

Findings:

  • Treatment for localized mediastinal leiomyosarcoma involves surgical excision, potentially combined with mediastinal radiotherapy.
  • Chemotherapy, typically with doxorubicin, is used for metastatic disease, though outcomes remain uncertain.

Related Experiment Videos

Implications:

  • Prognosis for mediastinal leiomyosarcoma is contingent upon tumor size, histological grade, and resectability.
  • Accurate diagnosis using specialized markers is crucial for appropriate treatment planning and patient management.